Company page

Evelo Biosciences, Inc.

Evelo Biosciences, Inc. (Ticker: EVLO) is a public company based in the United States with a market capitalization of approximately $19 billion. The company focuses on developing innovative therapies to treat various diseases through its proprietary microbiome-based platform. Evelo aims to leverage its scientific advancements to improve patient outcomes and address unmet medical needs in the healthcare sector.